The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008

Cost-of-Illness Studies

(2011) Allison Larg et al.   PHARMACOECONOMICS

Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic

(2010) P Hanova et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II

(2009) Louis P. Garrison et al.   VALUE IN HEALTH

Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic

(2008) Š. Forejtová et al.   CLINICAL RHEUMATOLOGY

Difficulties in Calculating Productivity Costs: Work Disability Associated with Borderline Personality Disorder

(2008) Antoinette D.I. van Asselt et al.   VALUE IN HEALTH

The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit

(2007) R. M. Ara et al.   RHEUMATOLOGY

The Burden of Ankylosing Spondylitis in Spain

(2007) Gisela Kobelt et al.   VALUE IN HEALTH